33 PRIMECAP Management BeiGene Ltd Trades
PRIMECAP Management acquired 5.09M BeiGene Ltd shares worth $940M. That's 0.68% of their equity portfolio (42nd largest holding). The investor owns 4.65% of the outstanding BeiGene Ltd stock. The first BeiGene Ltd trade was made in Q2 2017. Since then PRIMECAP Management bought shares eighteen more times and sold shares on fourteen occasions. The investor's estimated purchase price is $985M, resulting in a loss of 4.6%.
Avg closing price
Price range
Increased shares by 0.6% (+32.8k shares)
Q2 2025
Avg closing price
-
Price range
-
-
-
Sold 0.9% shares (-43.4k shares)
Q1 2025
Avg closing price
-
Price range
-
-
-
Increased shares by 2.5% (+125k shares)
Q4 2024
Avg closing price
$198.16
Price range
$176.33
-
$246.04
Sold 0.2% shares (-12k shares)
Q3 2024
Avg closing price
$179.61
Price range
$143.93
-
$224.51
Sold 0.3% shares (-15.6k shares)
Q2 2024
Avg closing price
$154.12
Price range
$129.52
-
$174.32
Increased shares by 0.3% (+13.2k shares)
Q1 2024
Avg closing price
$161.02
Price range
$141.80
-
$181.47
Sold 0.4% shares (-20.1k shares)
Q4 2023
Avg closing price
$180.91
Price range
$158.67
-
$201.58
Sold 0.1% shares (-5.91k shares)
Q3 2023
Avg closing price
$197.87
Price range
$179.87
-
$225.13
Sold 0.6% shares (-31.3k shares)
Q2 2023
Avg closing price
$230.28
Price range
$178.30
-
$266.78
Sold 0.0% shares (-2.23k shares)
Q1 2023
Avg closing price
$239.86
Price range
$215.53
-
$274.50
Increased shares by 6.6% (+313k shares)
Q4 2022
Avg closing price
$183.39
Price range
$125.51
-
$229.30
Increased shares by 17.5% (+704k shares)
Q3 2022
Avg closing price
$171.74
Price range
$131.80
-
$202.24
Increased shares by 8.7% (+323k shares)
Q2 2022
Avg closing price
$156.21
Price range
$121.11
-
$216.05
Sold 0.2% shares (-8.7k shares)
Q1 2022
Avg closing price
$212.59
Price range
$146.52
-
$269.56
Sold 2.5% shares (-93.8k shares)
Q4 2021
Avg closing price
$337.64
Price range
$248.56
-
$389.34
Sold 1.2% shares (-46.6k shares)
Q3 2021
Avg closing price
$326.95
Price range
$249.60
-
$403.14
Sold 0.8% shares (-30.9k shares)
Q2 2021
Avg closing price
$331.23
Price range
$292.75
-
$367.01
Increased shares by 15.5% (+522k shares)
Q1 2021
Avg closing price
$331.14
Price range
$260.64
-
$382.12
Sold 0.2% shares (-5.56k shares)
Q4 2020
Avg closing price
$275.32
Price range
$221.31
-
$316.61
Increased shares by 92.0% (+1.62M shares)
Q3 2020
Avg closing price
$235.04
Price range
$189.18
-
$286.44
News about BeiGene Ltd - ADR and PRIMECAP Management
Is BeiGene (BGNE) a Smart Long-Term Investment?
Longleaf Partners Fund, a Memphis-based fund under Southeastern Asset Management, published its ¡°Longleaf Partners Asia Pacific UCITS Fund¡± first quarter 202...